相关实验视频
Updated: May 12, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
398
治疗慢性病的新疗法
Andrew M Treihaft1, Manish A Parikh1,2, Kaedrea A Jackson3,4
1Department of Medicine, New York-Presbyterian Brooklyn Methodist Hospital, Brooklyn, USA.
Cureus
|May 8, 2025
概括
慢性病 (CKD) 在2型糖尿病 (T2DM) 患者中增加心血管风险. 阿尔多合成酶抑制剂 (ASIs) 显示出作为管理CKD进展的潜在第五支柱的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
背景情况:
- 慢性病 (CKD) 在2型糖尿病 (T2DM) 患者中显著提高心血管疾病和死亡率.
- 目前的CKD管理涉及生活方式的改变和四个药理支柱:RASi,SGLT2i,GLP-1RA和MRAs.
- 不完整的阿尔多激素阻塞有助于损伤的进展.
研究的目的:
- 探索阿尔多合成酶抑制剂 (ASIs) 作为CKD新治疗策略的潜力.
- 评估ASI在控制阿尔多激素活性中的作用及其对病进展的影响.
主要方法:
- 审查CKD管理当前的药理学方法.
- 对ASIs的早期阶段试验数据的分析,例如vicadrostat.
- 评估ASIs对白蛋白尿和潜在脏保护的影响.
主要成果:
- 早期的试验表明,ASIs可以减少白尿.
- ASI通过选择性抑制阿尔多斯特合成,显示出对脏的保护潜力.
- 保持皮质醇的产生是ASI作用的关键特征.
结论:
- 阿尔多合成酶抑制剂 (ASIs) 可能是CKD管理的新疗法支柱.
- ASI提供了一种有针对性的方法来解决不完整的阿尔多激素阻塞,这是CKD进展的一个因素.
- 需要进一步的研究来确定ASIs作为抑制T2DM患者中CKD进展的第五支柱.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
316
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
316
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Dialysis
231
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
231
Heart Failure Drugs: Diuretics
291
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
291
Antihypertensive Drugs: Direct Renin Inhibitors
443
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
443
Chronic Pancreatitis II: Collaborative Care
49
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
49

